ONE hundred and ninety saddle emboli at the aortic bifurcation have been reported to date. To these we are adding 3 cases, making a total of 193. Two of our 3 patients were treated by embolectomy, and ...

Surgical Pulmonary Embolectomy Outcomes Not Affected by Thrombus Location Surgical pulmonary embolectomy for peripheral distribution of thrombus demonstrated positive outcomes in patients with either ...

EMBOLIC occlusion of the main trunk of the superior mesenteric artery produces severe ischemia of the entire bowel between the terminal duodenum and mid-transverse colon. This entity must be ...

Tissue plasminogen activator can improve neurologic outcome after acute ischemic stroke (AIS); however, as an intravenous or catheter-based treatment strategy, it is not suitable for all AIS patients.

Often relegated to the second or third tier of treatment options, surgical management of patients with massive or high-risk submassive acute pulmonary embolism (PE)—either with embolectomy or ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Jupiter Endovascular, Inc. today announced that the SPIRARE II pivotal trial evaluating the use of the company’s Vertex™ Pulmonary Embolectomy System in patients ...

Recently Sir Thomas Lewis, eminent London heart specialist, made a special study of how an arm or leg dies when an embolus (floating clot) plugs a main artery which feeds blood to that limb. Competent ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™, announced today that the ...

* FDA- GOT 3 MEDICAL DEVICE REPORTS, NO REPORTS OF DEATH/ INJURY RELATED TO PYTHON EMBOLECTOMY, BARD EMBOLECTOMY, OTW LATIS CLEANING CATHETERS RECALL Source text: ...

Please provide your email address to receive an email when new articles are posted on . “SPIRARE opens the door for a new generation of large-bore interventional technology, designed for increased ...

Vertex Pulmonary Embolectomy System demonstrated significant right heart recovery, low adverse event rates, and reproducible performance across high-severity PE patients Jupiter Endovascular, Inc.